Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco L Schito

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2André Báfica, Charles A Scanga, Marco L Schito, et al.
The Journal of Infectious Diseases|March 16, 2010
Challenges for rapid molecular HIV diagnosticsMarco L Schito, M Patricia D'Souza, S Michele Owen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activationMarco L Schito, Oleg N Demidov, Shin'ichi Saito, et al.
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitorsJim A Turpin, Marco L Schito, Lisa M Miller Jenkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replicationOzlem Equils, Marco L Schito, Hiase Karahashi, et al.
Current HIV Research|July 18, 2006
Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeysMarco L Schito, Adam C Soloff, Danielle Slovitz, et al.
AIDS Research and Human Retroviruses|March 18, 2003
In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine modelMarco L Schito, Atul Goel, Yongsheng Song, et al.
Journal of Virology|July 10, 2009
Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infectionGregory S Wallace, Cecilia Cheng-Mayer, Marco L Schito, et al.
Nature Chemical Biology|October 19, 2010
Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transferLisa M Miller Jenkins, David E Ott, Ryo Hayashi, et al.
AIDS (London, England)|July 14, 2011
Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicideCecilia Cheng-Mayer, Yaoxing Huang, Agegnehu Gettie, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2André Báfica, Charles A Scanga, Marco L Schito, et al.
The Journal of Infectious Diseases|March 16, 2010
Challenges for rapid molecular HIV diagnosticsMarco L Schito, M Patricia D'Souza, S Michele Owen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activationMarco L Schito, Oleg N Demidov, Shin'ichi Saito, et al.
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitorsJim A Turpin, Marco L Schito, Lisa M Miller Jenkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replicationOzlem Equils, Marco L Schito, Hiase Karahashi, et al.
Current HIV Research|July 18, 2006
Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeysMarco L Schito, Adam C Soloff, Danielle Slovitz, et al.
AIDS Research and Human Retroviruses|March 18, 2003
In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine modelMarco L Schito, Atul Goel, Yongsheng Song, et al.
Journal of Virology|July 10, 2009
Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infectionGregory S Wallace, Cecilia Cheng-Mayer, Marco L Schito, et al.
Nature Chemical Biology|October 19, 2010
Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transferLisa M Miller Jenkins, David E Ott, Ryo Hayashi, et al.
AIDS (London, England)|July 14, 2011
Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicideCecilia Cheng-Mayer, Yaoxing Huang, Agegnehu Gettie, et al.
Pageof 1